Print this article

Didier Combis Director B.U. Exclusive Synthesis & PharmaChemicals

Keywords:

e-version image

Click HERE to download the PDF version





WHAT PARTS OF THE MARKET ARE DRIVING GROWTH FOR PCAS?

Besides our Specialty Chemical business which is doing well and focusing on highly complex chemicals mainly for the electronic industry, the pharma segment is extremely important and is a major growth driver for PCAS. In the past two years most of our growth came from custom manufacturing of pharma chemicals, APIs and GMP intermediates.


In December 2016 we acquired from